ACS Logo Analytical Control Systems, Inc

Analytical Control Systems, Inc.


 

Email ACS

info@analyticalcontrols.com

Phone ACS

317-841-0458

Fax ACS

317-841-3186

Mail ACS

Analytical Control Systems, Inc.

9058 Technology Drive
Fishers, IN 46038

 


All WebPages' contents are © 2002-2004 Analytical Control Systems, Inc.
Many of Analytical Control Systems, Inc. products are covered by US and foreign patents or patents pending.

Platelet Derived Growth Factor and Hemostatin™

Determination of Platelet Derived Growth Factor

Drs. Xiangdong Cui, M.D. and Dayong Gao, Ph.D. performed a study of Hemostatin’s™ effect on the release of growth factors from platelet activation at the Department of Mechanical Engineering and Center for Biomedical Engineering at the University of Kentucky.

Introduction: Platelet Derived Growth Factor (PDGF) is a potent mitogen/chemoattractant for connective tissue and plays an important role in wound healing and angiogenesis. The target cells for PDGF include mammalian cells, such as fibroblasts, endothelial cells, and smooth muscle cells. Our present experiment is to observe where the PDGF exists, how effective PDGF is for cell growth and to observe some related phenomenon about propyl gallate (PG) (Hemostatin™).

 

Materials and Methods:

1. Preparation of the samples:

a. Obtain platelets from the blood bank of UK hospital (fresh, 0 days old);

b. Adjust platelet count to 250,000/mm3 (with TB buffer);

c. Add 1 ml of PG reagent (1:1, or 1:5) and stir for 5 min.;

d. Divide the sample into supernatant and aggregates and freeze at –70°C for later use;

e. Take part of the platelet sample (2-3 ml), centrifuge to remove all of the platelets and get platelet poor plasma (PPP). Freeze at –70°C for later use.

2. Order the PDGF and relative chemicals from Promega:

Platelet Derived Growth Factor PDGF(AB), Human Recombinant; PDGF(AA), Human Recombinant; PDGF(BB), Human Recombinant; Transforming Growth Factor-alpha, Human Recombinant (rh TGF-a); Fibroblast Growth Factor, Basic, Human Recombinant (rh FGF, Basic); Fibroblast Growth Factor, Acidic, Human Recombinant (rh FGF, Acidic);

3. Order Balb/3T3, Clone A31 cells from ATCC:

a. One vial, seed and culture them for experimental use. The medium: DMEM/F12

4. CellTiter 96™ Non-radioactive Cell Proliferation/Cytotoxicity Assay.

a. Three days prior to performing this assay, seed 1-2X105 3T3 cells to t-75 flask in F12/DMEM supplemented with 10% calf serum;

b. The column 1 was set as the negative control;

c. Add 100 ml of the cell suspension (containing 10,000 cells) to each well of the 96 well plate and return to the incubator for 24 hours;

d. The next day, add 20 ml/well reagent and then continue to culture for 48 hours;

e. Add 15 ml/well of CellTiter 96™ Dye Solution and incubate the plate for 4 hours;

f. Add 10 ml/well of CellTiter 96™ Solubilization/Stop Solution and keep it at 37°C in an incubator overnight;

g. Record the absorbance at 570 nm using an Elisa plate reader. Use of a reference wavelength is optional (630 nm).

h. Plot the corrected absorbance at 570 nm (y– axis) versus ng/ml of growth factor (x- axis).

We found that PG can induce the platelets to aggregate and release PDGF, and the latter can enhance growth of cells. But, it may inhibit the condition of cells. In order to investigate this phenomenon, we did other experiments for the dose dependent test.

 

Results:

PDGF(AB)

Supernatant 12.5 ng/ml

Platelet debris 1.3 ng/ml

PPP 0 ng/ml

 

PDGF(AA)

Supernatant 18.1 ng/ml

Platelet debris 1.2 ng/ml

PPP 0 ng/ml

 

PDGF(BB)

Supernatant 11.6 ng/ml

Platelet debris 2.1 ng/ml

PPP 0 ng/ml

 

Rh FGF- Basic

Supernatant 7.5 ng/ml

Platelet debris 0 ng/ml

PPP 5.3 ng/ml

 

Rh FGF- Acidic

Supernatant 1.2 ng/ml

Platelet debris 0.7 ng/ml

PPP 6.8 ng/ml

 

TGF-a

Supernatant 1.4 ng/ml

Platelet debris 0 ng/ml

PPP 50.8 ng/ml

 

According to our experiments, the preliminary conclusions are that:

  1. PG is a potent reagent for platelet aggregation;
  2. Platelets can be thoroughly activated and broken and release PDGF by PG;
  3. Most of the PDGF is contained in the supernatant, with a few of them in the debris of the platelets;
  4. The mixed PG and PDGF solution can enhance growth of 3T3 cells in vitro;
  5. In the relatively high concentrations of PG only, PG could inhibit the proliferation of the cells;
  6. When comparing the dialyzed and non-dialyzed platelets freeze dried crystal, the efficiency of dialyzed is better.

 

wpe33.jpg (9414 bytes)

wpe34.jpg (9875 bytes)

wpe35.jpg (14425 bytes)

wpe36.jpg (15356 bytes)

wpe37.jpg (16057 bytes)

 

wpe1.jpg (5287 bytes) Return to SPAT™/PAA™ Research Index